Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NasalCrom extensions?

This article was originally published in The Tan Sheet

Executive Summary

Formulation, dosage research on cromolyn sodium 4% nasal spray could lead to expansion of Pharmacia's OTC allergic rhinitis treatment/prevention remedy. "Research approaches being considered are to evaluate less-frequent dosing, including increasing the number of sprays of cromolyn per administration, increasing the concentration of the agent, titrating from the current to a lower dosage and using on an as-needed basis," Paul Ratner, MD, University of Texas Health Sciences Center, et al., state in review article funded by Pharmacia, published in April Mayo Clinic Proceedings...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093884

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel